|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US6040157A
(en)
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
|
US6734285B2
(en)
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
|
DK0751992T3
(da)
|
1994-03-08 |
2006-03-06 |
Human Genome Sciences Inc |
Karendotelvækstfaktor 2
|
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
|
US6783980B2
(en)
|
1995-06-15 |
2004-08-31 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
|
US7727761B2
(en)
|
1995-08-01 |
2010-06-01 |
Vegenics Limited |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
|
PT848755E
(pt)
|
1995-09-08 |
2003-12-31 |
Genentech Inc |
Proteina relacionada com o vegf
|
|
US7125714B2
(en)
|
1997-02-05 |
2006-10-24 |
Licentia Ltd. |
Progenitor cell materials and methods
|
|
JP2002505873A
(ja)
*
|
1998-03-13 |
2002-02-26 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
血管内皮増殖因子２
|
|
DE19813774A1
(de)
*
|
1998-03-27 |
1999-09-30 |
Max Planck Gesellschaft |
Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF)
|
|
WO1999049882A2
(en)
*
|
1998-03-27 |
1999-10-07 |
Eicher Dorothea J |
Vegf and vegf-c as infant formula supplements
|
|
DE69928411D1
(de)
|
1998-09-08 |
2005-12-22 |
Agouron Pharma |
Modifikationen des vegf-rezeptor-2 proteins und verfahren zu seiner verwendung
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
EP1568375A1
(en)
*
|
1998-10-26 |
2005-08-31 |
Ludwig Institute For Cancer Research |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
|
WO2000024412A2
(en)
*
|
1998-10-26 |
2000-05-04 |
Ludwig Institute For Cancer Research |
Use of vegf-c or vegf-d gene or protein to prevent restenosis
|
|
WO2000024415A2
(en)
|
1998-10-28 |
2000-05-04 |
Cornell Research Foundation, Inc. |
Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
|
|
US6783953B1
(en)
|
1998-12-22 |
2004-08-31 |
Janssen Pharmaceutica N.V. |
Vascular endothelial growth factor-X
|
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
WO2003104467A1
(en)
|
2002-04-25 |
2003-12-18 |
Crucell Holland B.V. |
Means and methods for the production of adenovirus vectors
|
|
AU4643501A
(en)
*
|
2000-02-04 |
2001-08-14 |
Flanders Interuniversity Institute For Biotechnology (Vib) |
Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
|
|
US7727971B2
(en)
|
2000-02-04 |
2010-06-01 |
Life Sciences Research Partners Vzw |
Use of placental growth factor for treating ischemic muscle disease
|
|
US20040023863A1
(en)
|
2000-04-06 |
2004-02-05 |
Franco Wayne P. |
Methods of use growth factors for treating heart disease
|
|
EP1157999A1
(en)
*
|
2000-05-24 |
2001-11-28 |
Introgene B.V. |
Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
|
|
KR20020059609A
(ko)
|
2000-08-04 |
2002-07-13 |
벤슨 로버트 에이치. |
혈관 내피 성장 인자 ２
|
|
WO2002014367A1
(fr)
|
2000-08-10 |
2002-02-21 |
Center For Advanced Science And Technology Incubation,Ltd. |
Facteur de croissance chimere de cellules endotheliales vasculaires de type humain
|
|
DE60138403D1
(de)
|
2000-09-26 |
2009-05-28 |
Crucell Holland Bv |
Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
|
|
EP1191104A1
(en)
*
|
2000-09-26 |
2002-03-27 |
Introgene B.V. |
Gene delivery vehicles and use thereof in the preparation of a medicament and/or vaccine
|
|
WO2002046412A2
(en)
|
2000-12-07 |
2002-06-13 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
JP2004536579A
(ja)
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
血管内皮増殖因子２
|
|
NZ529915A
(en)
*
|
2001-06-20 |
2007-07-27 |
Ludwig Inst Cancer Res |
Stimulation of vascularization of ischemic tissue by angiogenesis with VEGF-B186
|
|
CA2462374C
(en)
|
2001-10-15 |
2011-01-18 |
Janssen Pharmaceutica N.V. |
Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
|
|
WO2006055743A2
(en)
*
|
2004-11-18 |
2006-05-26 |
Franco, Wayne |
Compbination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
WO2010078624A1
(en)
*
|
2009-01-07 |
2010-07-15 |
Vegenics Limited |
Materials and methods for the treatment of hypertension
|
|
CN118546231B
(zh)
*
|
2024-06-28 |
2026-01-30 |
温州医科大学 |
一种修复皮肤屏障的vegf改构蛋白及其在植物中表达的方法
|